Skip to main content
. 2014 Apr;99(4):779–787. doi: 10.3324/haematol.2013.094151

Figure 4.

Figure 4.

Detection of free and complexed antibodies in patients with acquired TTP treated with rituximab and in remission for at least 1 year. Plasma samples from patients (1–10) treated with rituximab during the acute event were analyzed by ELISA for the presence of free and complexed IgG anti-ADAMTS13 antibodies during clinical remission. The duration of remission (y=years) is shown for each patient. ADAMTS13-specific immune complexes were mainly of subclass IgG4. IC: immune complexes.